BackLatigo Biotherapeutics Overview

Latigo Biotherapeutics Receivables

Track Latigo Biotherapeutics's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Latigo Biotherapeutics Receivables History

Loading

Latigo Biotherapeutics vs. peers: Receivables Comparison

Loading

Latigo Biotherapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Latigo Biotherapeutics (LTGO) FAQ

Latigo Biotherapeutics posts a receivables of $0 as of September 2026. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

Receivables is one piece of Latigo Biotherapeutics's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for LTGO's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Latigo Biotherapeutics's other metric pages and overview cover the third.

Questions & Answers